IPP Bureau
American Oncology Institute highlights spirit of women cancer survivors
By IPP Bureau - March 08, 2022
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
Sense receives CE marking for Veros Covid-19 instrument-free molecular test
By IPP Bureau - March 08, 2022
Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions
GOQii survey points to rise in women medical issues
By IPP Bureau - March 08, 2022
Women's health is in fact a direct reflection of the nation's overall health
Toyobo invests in US-based biotech startup DMC Biotechnologies
By IPP Bureau - March 08, 2022
Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts
Lonza completes expansion of API manufacturing Lab in Nansha, China
By IPP Bureau - March 08, 2022
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
Vantage Specialty Chemicals acquires JEEN
By IPP Bureau - March 08, 2022
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
Cionic’s Neural Sleeve granted USFDA clearance
By IPP Bureau - March 08, 2022
Neural sleeve first algorithm-powered bionic garment designed to help those with mobility issues due to multiple sclerosis, stroke, cerebral palsy, and other conditions, regain functional movement in everyday activities
AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer
By IPP Bureau - March 07, 2022
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO
By IPP Bureau - March 07, 2022
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Zydus’ OxemiaTM receives approval from DCGI to treat Anaemia associated with Chronic Kidney Disease
By IPP Bureau - March 07, 2022
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Thermo Fisher Scientific unveils new genetic analyzer
By IPP Bureau - March 07, 2022
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Jardiance is first and only treatment approved in Europe for chronic heart failure
By IPP Bureau - March 07, 2022
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru
By IPP Bureau - March 07, 2022
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
Medtronic launches device to simplify type 1 diabetes management
By IPP Bureau - March 07, 2022
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
Evonik invests in US-based 3D screen printing technology firm Laxxon Medical
By IPP Bureau - March 07, 2022
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
